Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 19-Dec-23 6:39 PM View:  | Pace Gary W Director | TrovaGene, Inc. (CRDF) | 19-Dec-23 | Private Purchase | 30,000 | $1.37 | $41,100.00 | 4% 667.76K to 697.76K | |
| 14-Nov-23 10:00 PM View: | Pace Gary W Director | TrovaGene, Inc. (CRDF) | 10-Nov-23 | Private Purchase | 22,950 | $0.98 | $22,491.00 | 4% 644.81K to 667.76K | |
| 29-Nov-22 4:11 PM View: | Erlander Mark Chief Executive Officer Director | TrovaGene, Inc. (CRDF) | 25-Nov-22 | Private Purchase | 10,000 | $1.43 | $14,300.00 | 69% 14.48K to 24.48K | |
| 20-Sep-22 6:08 PM View: | White Lale Director | TrovaGene, Inc. (CRDF) | 19-Sep-22 | Private Purchase | 15,000 | $1.63 | $24,525.00 | 15% 98.79K to 113.79K | |
| 19-Sep-22 8:37 AM View: | Levine James E. Chief Financial Officer | TrovaGene, Inc. (CRDF) | 16-Sep-22 | Private Purchase | 30,000 | $1.56 | $46,710.00 | 100% 30.0K to 60.0K | |
| 11-Oct-22 4:22 PM View: | Armitage James O Director | TrovaGene, Inc. (CRDF) | 16-Sep-22 | Private Purchase | 13,000 | $1.56 | $20,233.20 | 100% 0 to 13.0K | |
| 19-Sep-22 8:37 AM View: | Pace Gary W Director | TrovaGene, Inc. (CRDF) | 15-Sep-22 | Private Purchase | 150,000 | $1.71 | $256,500.00 | 30% 494.81K to 644.81K | |
| 19-Sep-22 8:37 AM View: | Tannenbaum Renee P Director | TrovaGene, Inc. (CRDF) | 15-Sep-22 | Private Purchase | 10,000 | $1.72 | $17,168.00 | 100% 0 to 10.0K | |
| 06-Jul-22 4:10 PM View: | White Lale Director | TrovaGene, Inc. (CRDF) | 05-Jul-22 | Option Exercise | 28,858 | $2.60 | $75,030.80 | 41% 69.93K to 98.79K | |
| 22-Sep-21 10:00 PM View: | Pace Gary W Director | TrovaGene, Inc. (CRDF) | 21-Sep-21 | Market Purchase | 30,000 | $6.75 | $202,500.00 | 6% 464.81K to 494.81K | 9% |
| 13-Sep-21 8:12 AM View: | Levine James E. Chief Financial Officer | TrovaGene, Inc. (CRDF) | 10-Sep-21 | Market Purchase | 30,000 | $6.47 | $194,000.00 | 100% 0 to 30.0K | (3%) |
| 29-Mar-21 1:38 PM View: | Markin Rodney S Director | TrovaGene, Inc. (CRDF) | 26-Mar-21 | Market Purchase | 2,900 | $10.32 | $29,933.20 | 10% 28.16K to 31.06K | (4%) |
| 23-Mar-21 12:24 PM View: | Erlander Mark Chief Executive Officer | TrovaGene, Inc. (CRDF) | 23-Mar-21 | Market Purchase | 965 | $10.34 | $9,979.74 | 7% 13.52K to 14.48K | 3% |
| 23-Mar-21 3:57 PM View: | Jacob Gary S Director | TrovaGene, Inc. (CRDF) | 23-Mar-21 | Market Purchase | 2,370 | $10.42 | $24,689.40 | 12% 19.55K to 21.92K | (3%) |
| 24-Mar-21 10:27 AM View: | Pace Gary W Director | TrovaGene, Inc. (CRDF) | 23-Mar-21 | Market Purchase | 10,000 | $10.23 | $102,300.00 | 2% 454.81K to 464.81K | (2%) |
| 23-Mar-21 2:30 PM View: | Kelemen Vicki Exec. VP and COO | TrovaGene, Inc. (CRDF) | 23-Mar-21 | Market Purchase | 960 | $10.31 | $9,897.60 | 19% 5.09K to 6.05K | (< 1%) |
| 22-Mar-21 6:35 PM View: | Brancaccio John P Director | TrovaGene, Inc. (CRDF) | 22-Mar-21 | Market Purchase | 3,000 | $10.95 | $32,850.00 | 32% 9.26K to 12.26K | 5% |
| 27-May-21 5:14 PM View: | Armitage James O Director | TrovaGene, Inc. (CRDF) | 19-Mar-21 | Market Purchase | 4,000 | $10.82 | $43,271.20 | 38% 10.49K to 14.49K | (28%) |
| 19-Mar-21 11:34 AM View: | Pace Gary W Director | TrovaGene, Inc. (CRDF) | 18-Mar-21 | Market Purchase | 3,000 | $10.55 | $31,660.00 | < 1% 451.81K to 454.81K | (2%) |
| 04-Mar-21 8:46 PM View: | Pace Gary W Director | TrovaGene, Inc. (CRDF) | 04-Mar-21 | Market Purchase | 1,500 | $9.27 | $13,897.50 | < 1% 450.31K to 451.81K | |
| 05-Jan-21 4:04 PM View: | Kelemen Vicki Exec. VP and COO | TrovaGene, Inc. (CRDF) | 02-Jan-21 | Option Exercise | 70 | -- | -- | 1% 5.05K to 5.12K | |
| 05-Jan-21 4:03 PM View: | Erlander Mark Chief Executive Officer | TrovaGene, Inc. (CRDF) | 02-Jan-21 | Payment of Exercise | 113 | -- | -- | (< 1%) 13.63K to 13.52K | |
| 05-Jan-21 4:04 PM View: | Kelemen Vicki Exec. VP and COO | TrovaGene, Inc. (CRDF) | 02-Jan-21 | Payment of Exercise | 31 | -- | -- | (< 1%) 5.12K to 5.09K | |
| 05-Jan-21 4:03 PM View: | Erlander Mark Chief Executive Officer | TrovaGene, Inc. (CRDF) | 02-Jan-21 | Option Exercise | 260 | -- | -- | 2% 13.37K to 13.63K | |
| 25-Nov-20 4:02 PM View: | Kelemen Vicki Exec. VP and COO | TrovaGene, Inc. (CRDF) | 23-Nov-20 | Option Exercise | 35,321 | $2.48 | $87,596.10 | 699% 5.05K to 40.38K | 10% |
| 25-Nov-20 4:02 PM View: | Kelemen Vicki Exec. VP and COO | TrovaGene, Inc. (CRDF) | 23-Nov-20 | Market Option Sale | 35,321 | $18.60 | $657,020.00 | (87%) 40.38K to 5.05K | |
| 17-Sep-20 9:42 AM View: | Pace Gary W Director | TrovaGene, Inc. (CRDF) | 16-Sep-20 | Market Purchase | 2,550 | $5.70 | $14,526.50 | < 1% 447.76K to 450.31K | |
| 18-May-20 4:16 PM View: | Jacob Gary S Director | TrovaGene, Inc. (CRDF) | 14-May-20 | Market Purchase | 17,483 | $1.43 | $25,000.70 | 845% 2.07K to 19.55K | |
| 18-May-20 4:15 PM View: | Armitage James O Director | TrovaGene, Inc. (CRDF) | 14-May-20 | Market Purchase | 10,490 | $1.43 | $15,000.70 | 100% 0 to 10.49K | |
| 18-May-20 4:15 PM View: | Adams Thomas Phd Director | TrovaGene, Inc. (CRDF) | 14-May-20 | Market Purchase | 13,986 | $1.43 | $20,000.00 | 286% 4.89K to 18.88K | |
| 18-May-20 4:16 PM View: | Markin Rodney S Director | TrovaGene, Inc. (CRDF) | 14-May-20 | Market Purchase | 20,979 | $1.43 | $30,000.00 | 292% 7.18K to 28.16K | |
| 18-May-20 4:16 PM View: | White Lale Director | TrovaGene, Inc. (CRDF) | 14-May-20 | Market Purchase | 69,930 | $1.43 | $99,999.90 | 100% 0 to 69.93K | |
| 18-May-20 4:17 PM View: | Erlander Mark Chief Executive Officer | TrovaGene, Inc. (CRDF) | 14-May-20 | Market Purchase | 6,993 | $1.43 | $9,999.99 | 110% 6.38K to 13.37K | |
| 18-May-20 4:16 PM View: | Brancaccio John P Director | TrovaGene, Inc. (CRDF) | 14-May-20 | Market Purchase | 6,993 | $1.43 | $9,999.99 | 308% 2.27K to 9.26K | |
| 13-May-20 4:16 PM View: | Pace Gary W Director | TrovaGene, Inc. (CRDF) | 11-May-20 | Market Purchase | 447,761 | $1.34 | $600,000.00 | 100% 0 to 447.76K | |
| 03-Jan-20 4:10 PM View: | Erlander Mark Chief Scientific Officer | TrovaGene, Inc. (CRDF) | 03-Jan-20 | Payment of Exercise | 552 | -- | -- | (8%) 6.78K to 6.23K | |
| 03-Jan-20 4:15 PM View: | Erlander Mark Chief Scientific Officer | TrovaGene, Inc. (CRDF) | 03-Jan-20 | Payment of Exercise | 116 | -- | -- | (2%) 6.49K to 6.38K | |
| 03-Jan-20 4:15 PM View: | Erlander Mark Chief Scientific Officer | TrovaGene, Inc. (CRDF) | 02-Jan-20 | Option Exercise | 261 | -- | -- | 4% 6.23K to 6.49K | |
| 03-Jan-20 4:10 PM View: | Erlander Mark Chief Scientific Officer | TrovaGene, Inc. (CRDF) | 01-Jan-20 | Option Exercise | 1,250 | -- | -- | 23% 5.53K to 6.78K | |
| 03-Oct-19 4:16 PM View: | Erlander Mark Chief Scientific Officer | TrovaGene, Inc. (CRDF) | 01-Oct-19 | Payment of Exercise | 466 | -- | -- | (8%) 6.0K to 5.53K | |
| 03-Oct-19 4:16 PM View: | Erlander Mark Chief Scientific Officer | TrovaGene, Inc. (CRDF) | 01-Oct-19 | Option Exercise | 1,250 | -- | -- | 26% 4.75K to 6.0K | |
| 03-Jul-19 6:21 AM View: | Erlander Mark Chief Scientific Officer | TrovaGene, Inc. (CRDF) | 01-Jul-19 | Payment of Exercise | 461 | -- | -- | (9%) 5.21K to 4.75K | |
| 03-Jul-19 6:21 AM View: | Erlander Mark Chief Scientific Officer | TrovaGene, Inc. (CRDF) | 01-Jul-19 | Option Exercise | 1,250 | -- | -- | 32% 3.96K to 5.21K | |
| 03-Apr-19 4:00 PM View: | Erlander Mark Chief Scientific Officer | TrovaGene, Inc. (CRDF) | 01-Apr-19 | Payment of Exercise | 459 | -- | -- | (10%) 4.42K to 3.96K | |
| 03-Apr-19 4:00 PM View: | Erlander Mark Chief Scientific Officer | TrovaGene, Inc. (CRDF) | 01-Apr-19 | Option Exercise | 1,250 | -- | -- | 39% 3.17K to 4.42K | |
| 04-Jan-19 4:10 PM View: | Erlander Mark Chief Scientific Officer | TrovaGene, Inc. (CRDF) | 02-Jan-19 | Payment of Exercise | 698 | -- | -- | (4%) 19.71K to 19.01K | |
| 04-Jan-19 4:10 PM View: | Erlander Mark Chief Scientific Officer | TrovaGene, Inc. (CRDF) | 02-Jan-19 | Option Exercise | 1,563 | -- | -- | 9% 18.14K to 19.71K | |
| 04-Jan-19 4:05 PM View: | Erlander Mark Chief Scientific Officer | TrovaGene, Inc. (CRDF) | 01-Jan-19 | Payment of Exercise | 3,035 | -- | -- | (14%) 21.18K to 18.14K | |
| 04-Jan-19 4:05 PM View: | Erlander Mark Chief Scientific Officer | TrovaGene, Inc. (CRDF) | 01-Jan-19 | Option Exercise | 7,500 | -- | -- | 55% 13.68K to 21.18K | |
| 03-Oct-18 5:09 PM View: | Erlander Mark Chief Scientific Officer | TrovaGene, Inc. (CRDF) | 01-Oct-18 | Payment of Exercise | 2,731 | -- | -- | (17%) 16.41K to 13.68K |
